|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenues, net | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Selling, general and administrative | |||||
| Loss from operations | |||||
| Loss on equity method investment | |||||
| Interest income | |||||
| Loss on extinguishment of debt | |||||
| Interest expense | |||||
| Loss from change in fair value of promissory notes | |||||
| Warrant related expenses (Note 10) | |||||
| Warrant inducement expenses (Note 10) | |||||
| Gain from change in fair value of warrant liability | |||||
| Loss before income taxes | |||||
| Income tax (benefit) expense | |||||
| Net loss | |||||
| Per share information: | |||||
| Net loss per share of common stock, basic (in dollars per share) | |||||
| Net loss per share of common stock, diluted (in dollars per share) | |||||
| Weighted average shares outstanding, basic (in shares) | |||||
| Weighted average shares outstanding, diluted (in shares) | |||||
Loading...